Researchers at the Gladstone Institute of Neurological Disease at the University of California San Francisco have found that removing a brain enzyme that regulates the concentration of arachidonic acid, a fatty acid, reduces cognitive deficits in a mouse model of Alzheimer’s disease (AD). The discovery, reported in Nature Neuroscience, may one day lead to a novel therapeutic strategy for the disease.
More on the link between Alzheimer’s disease and arachidonic acid here.
Posted by David Bradley on Monday, October 20th, 2008 at 10:01 am.
Click for newsfeed
